Revance Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Revance Therapeutics (RVNC) Prices 3.25M Common Offering at $36/Share
November 4, 2015 7:08 AM ESTRevance Therapeutics (NASDAQ: RVNC) announced the pricing of its underwritten public offering of 3,250,000 shares of its common stock at a price to the public of $36.00 per share. Revance also granted the underwriters a 30-day option to acquire an additional 487,500 shares from Revance. The offering... More
Revance Therapeutics (RVNC) Announces 3.25M Stock Offering
November 2, 2015 6:25 AM ESTRevance Therapeutics (NASDAQ: RVNC) announced a proposed underwritten public offering of 3,250,000 shares of its common stock. Revance expects to grant the underwriters a 30-day option to acquire an additional 487,500shares. The offering is subject to market and other conditions, and there... More
